The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Growth factor delivery: How surface interactions modulate release in vitro and in vivo
Open accessAbstract
Biomaterial scaffolds have been extensively used to deliver growth factors to induce new bone formation. The pharmacokinetics of growth factor delivery has been a critical regulator of their clinical success. This review will focus on the surface interactions that control the non-covalent incorporation of growth factors into scaffolds and the mechanisms that control growth factor release from clinically relevant biomaterials. We will focus on the delivery of recombinant human bone morphogenetic protein-2 from materials currently used in the clinical practice, but also suggest how general mechanisms that control growth factor incorporation and release delineated with this growth factor could extend to other systems. A better understanding of the changing mechanisms that control growth factor release during the different stages of preclinical development could instruct the development of future scaffolds for currently untreatable injuries and diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology
Peppas, N. A., Hilt, J. Z., Khademhosseini, A., & Langer, R. (2006) · Advanced Materials · doi:10.1002/adma.200501612 · Cited by 4,109
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Non-canonical amino acids in protein engineering
Link, A. J., Mock, M. L., & Tirrell, D. A. (2003) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2003.10.011 · Cited by 393
Enhancement of bone defect healing in old rats by TGF-β and IGF-1
Blumenfeld, I., Srouji, S., Lanir, Y., Laufer, D., & Livne, E. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00215-7 · Cited by 77
Cited by
Ho-Shui-Ling, A., Bolander, J., Rustom, L. E., Johnson, A. W., Luyten, F. P., & Picart, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.017 · Cited by 961
Bone tissue engineering via growth factor delivery: from scaffolds to complex matrices
De Witte, T.-M., Fratila-Apachitei, L. E., Zadpoor, A. A., & Peppas, N. A. (2018) · Regenerative Biomaterials · doi:10.1093/rb/rby013 · Cited by 513
Amani, H., Arzaghi, H., Bayandori, M., Dezfuli, A. S., Pazoki‐Toroudi, H., Shafiee, A., & Moradi, L. (2019) · Advanced Materials Interfaces · doi:10.1002/admi.201900572 · Cited by 436
Hydrogel‐Based Growth Factor Delivery Platforms: Strategies and Recent Advances
Shan, B., & Wu, F. (2024) · Advanced Materials · doi:10.1002/adma.202210707 · Cited by 430
Bone Morphogenetic Protein-2 in Development and Bone Homeostasis
Halloran, D., Durbano, H. W., & Nohe, A. (2020) · Journal of Developmental Biology · doi:10.3390/jdb8030019 · Cited by 348
Strategies to engineer tendon/ligament-to-bone interface: Biomaterials, cells and growth factors
Font Tellado, S., Balmayor, E. R., & Van Griensven, M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.004 · Cited by 286
Advances in Growth Factor Delivery for Bone Tissue Engineering
Oliveira, É. R., Nie, L., Podstawczyk, D., Allahbakhsh, A., Ratnayake, J., Brasil, D. L., & Shavandi, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020903 · Cited by 258
Kim, T.-H., Yun, Y.-P., Park, Y.-E., Lee, S.-H., Yong, W., Kundu, J., Jung, J. W., Shim, J.-H., Cho, D.-W., Kim, S. E., et al. (2014) · Biomedical Materials · doi:10.1088/1748-6041/9/2/025008 · Cited by 42
Nijhuis, A. W. G., van den Beucken, J. J. J. P., Boerman, O. C., Jansen, J. A., & Leeuwenburgh, S. C. G. (2013) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2012.0313 · Cited by 37
Metadata
- Authors
- King, W. J., & Krebsbach, P. H.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 64
- Issue
- 12
- Pages
- 1239-1256
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2039318841
- Cited by
- 192
- References
- 4
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.